RPRX icon

Royalty Pharma
RPRX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$48
3% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citigroup
Citigroup
Geoff Meacham
100% 1-yr RPRX win rate
27 Jan ‘26 1 month ago
TD Cowen
TD Cowen
Steve Scala
100% 1-yr RPRX win rate
11 Dec ‘25 2 months ago